Search results for: 'rare bearings'

17 Aug 2020  |  Global  |  Market Research

Affordable Housing Driving the Global Market for Construction Plastics, 2020

Geographic Expansion Boosts Growth Opportunities in Non-load-bearing Structures

Infographics

×

The construction plastics market comprises polyvinyl chloride (PVC), polyethylene (PE), polypropylene (PP), polycarbonate (PC), acrylonitrile butadiene styrene (ABS), polyamide (PA), polymethyl methacrylate (PMMA), and polyoxymethylene (POM). By end-use industry, the market has been further divided into pipes and ducts, windows and doors, wall cove...

01 Mar 2022  |  Global  |  Market Research

Global Thermography Condition Monitoring Growth Opportunities

Future Growth Potential of Thermography Monitoring in Identifying Hidden Anomalies

Infographics

×

Thermography is used for predictive condition maintenance and energy conservation in a majority of the substantial applications within the petrochemical, steel, process, and semiconductor industries. This technique is a non-destructive, non-contact method that can be used for a wide range of high-temperature applications, such as maintenance of ele...

This strategic analysis is part of Frost & Sullivans continued coverage of the U.S. retail toll-free services market space. Toll-free services were historically designed to provide businesses with a convenient way for their regional, national, and international customers and suppliers to call inbound without requiring the callers to bear the cost ...

The treatment of rare diseases requires the use of specialized drugs. Patient populations for rare diseases are most often quite small, consequently the products treating them earn the designation orphan drugs. These drugs must undergo the research, development, and clinical trials that all drugs do, yet the investment into the development is great...

The global CGT therapeutics market is transitioning from a niche, high-complexity segment into a mainstream, high-growth therapeutic class. Driven by scientific breakthroughs, accelerated regulatory pathways, and the entry of next-generation platforms—including in vivo CRISPR gene editing, allogeneic “off-the-shelf” cell therapies, and automated sm...

Existing (legacy) systems cannot address the operations, orchestration and monetization requirements that the above-listed transformational initiatives bring to bear. New systems are the ultimate answer, but addressing the “legacy gap” left by existing systems cannot come from a mandate to rip and replace. Installed networks continue to rely on the...

The alternative fuels sector is entering a critical phase where execution, not ambition, determines leadership. Success hinges first on overcoming legacy cultural constraints, enabling faster decision-making, experimentation, and partnership-led innovation. At the same time, firms must standardize regulatory intelligence to navigate fragmented poli...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping therapeutics, diagnostics, and drug delivery across infectious diseases, oncology, rare genetic disorders, autoimmune conditions, cardiovascular disease, pulmonary fibrosis, neurodegeneratio...

There have been increasing incidences of rare ophthalmic diseases (e.g., retinitis pigmentosa, Stargardt disease, Leber congenital amaurosis) and prevalent diseases (e.g., age-related macular degeneration [AMD], geographic atrophy). While clinicians have used small molecules as the conventional therapeutic modality to manage these diseases, the urg...